COHERUS ONCOLOGY INC

$CHRS
Institutional coverage

151 13F filers hold $CHRS.

13F holders
151
Insider buys · 90d
0
Congress · 90d
0

Smart Money · top-200 alpha cohort

4 holders · Q1 2026

$CHRS is held by 4 managers from the Top-Performer cohort as of Q1 2026. Position weights range from 0.00% to 0.00%, with an average of 0.00% of portfolio. Largest holder: ADAR1 Capital Management, LLC at 0.00%. A weekly Smart-Money commentary for this ticker has not been generated yet this batch — the table below shows the full cohort positioning.

Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.

Institutional holders

Top 10 of 151 · Source: 13F-HR
01
Gimbal Financial
3.13% of portfolio
4,200,000 sh
02
KPCB DGF II Associates, LLC
0.07% of portfolio
3,856,928 sh
03
Castleview Partners, LLC
0.56% of portfolio
3,428,571 sh
04
Newbrook Capital Advisors LP
0.09% of portfolio
3,036,076 sh
05
Axa S.a.
2,325,859 sh
06
Leuthold Group, LLC
2,302,001 sh
07
Confluence Investment Management LLC
0.01% of portfolio
2,250,000 sh
08
State Street
2,223,396 sh
09
Mason Capital Management LLC
0.16% of portfolio
1,886,748 sh
10
Wasatch Advisors LP
0.01% of portfolio
1,459,310 sh
See all 151 13F holders · Pro →

Insider activity · last 90 days

1 transactions · 1 filers
23 May 2025
Wahlstrom Mats
▼ SOLD
99,988
$0.74
S

Transaction codes: P open-market purchase · S sale · M option exercise · A grant · F tax-withhold sale. Insider names link to each individual's expert page.

Congress trades · last 90 days

No Congress trades

No STOCK Act filings reference $CHRS in the recent window.

Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 07:53 UTC.